Literature DB >> 17989497

Abnormal bone and mineral metabolism in kidney transplant patients--a review.

Stuart M Sprague1, Vasily Belozeroff, Mark D Danese, Lynn P Martin, Klaus Olgaard.   

Abstract

BACKGROUND/AIMS: Abnormal bone and mineral metabolism is common in patients with kidney failure and often persists after successful kidney transplant.
METHODS: To better understand the natural history of this disease in transplant patients, we reviewed the literature by searching MEDLINE for English language articles published between January 1990 and October 2006 that contained Medical Subject Headings and key words related to secondary or persistent hyperparathyroidism and kidney transplant.
RESULTS: Parathyroid hormone levels decreased significantly during the first 3 months after transplant but typically stabilized at elevated values after 1 year. Calcium tended to increase after transplant and then stabilize at the higher end of the normal range within 2 months. Phosphorus decreased rapidly to within or below normal levels after surgery and hypophosphatemia, if present, resolved within 2 months. Low levels of 1,25(OH)2 vitamin D typically did not reach normal values until almost 18 months after transplant.
CONCLUSION: This review provides evidence demonstrating that abnormal bone and mineral metabolism exists in patients after kidney transplant and suggests the need for treatment of this condition. However, better observational and interventional research is needed before advocating such a treatment guideline. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989497     DOI: 10.1159/000110875

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  12 in total

Review 1.  Mineral and Bone Disease in Kidney Transplant Recipients.

Authors:  Ariella M Altman; Stuart M Sprague
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 2.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

3.  Parathyroid hormone levels in long-term renal transplant children and adolescents.

Authors:  Isabella Guzzo; Giacomo Di Zazzo; Chiara Laurenzi; Lucilla Ravà; Germana Giannone; Stefano Picca; Luca Dello Strologo
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.714

4.  Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.

Authors:  Csaba Ambrus; Miklos Zsolt Molnar; Maria Eszter Czira; Laszlo Rosivall; Istvan Kiss; Adam Remport; Miklos Szathmari; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-08-22       Impact factor: 2.370

5.  Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens.

Authors:  B J Edwards; A Desai; J Tsai; H Du; G R Edwards; A D Bunta; A Hahr; M Abecassis; S Sprague
Journal:  J Osteoporos       Date:  2011-09-12

6.  Fibroblast Growth Factor and Mineral Metabolism Parameters among Prevalent Kidney Transplant Patients.

Authors:  Madhumathi Rao; Priyanka Jain; Temitope Ojo; Gautam Surya; Vaidyanathapuram Balakrishnan
Journal:  Int J Nephrol       Date:  2012-07-02

7.  Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation.

Authors:  Ursula Thiem; Alois Gessl; Kyra Borchhardt
Journal:  Biomed Res Int       Date:  2015-03-10       Impact factor: 3.411

8.  A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.

Authors:  Myles Wolf; Matthew R Weir; Nelson Kopyt; Roslyn B Mannon; Jon Von Visger; Hongjie Deng; Susan Yue; Flavio Vincenti
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

9.  Improvements in renal replacement therapy practice patterns in estonia.

Authors:  Külli Kõlvald; Ulle Pechter; Merike Luman; Madis Ilmoja; Mai Ots-Rosenberg
Journal:  Nephron Extra       Date:  2014-07-10

10.  Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients.

Authors:  Zsofia K Nemeth; Nicoleta G Mardare; Maria E Czira; Gyorgy Deak; Istvan Kiss; Zoltan Mathe; Adam Remport; Akos Ujszaszi; Adrian Covic; Miklos Z Molnar; Istvan Mucsi
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.